Aspen review
Publishes every price tier before intake, but its 'monthly' plan bills three months upfront, the provider picks your molecule, and Mississippi and Louisiana are excluded.
- Semaglutide
- $299/mo (3-mo commit)
- Tirzepatide
- $399/mo (3-mo commit)
- Coverage
- 48 states
- Brand-name
- Compounded only
The scorecard
Aspen scored on our six published factors. See the methodology.
What we like
- Every tier for both molecules is published before intake, with the prepaid total shown next to each per-month figure
- Price is flat at every dose — 'same price at every dose, no surprises' — so titrating up does not raise the bill
- Names its dispensing pharmacy, Red Rock Compounding Pharmacy of Springville, Utah
- Offers a money-back guarantee to qualifying patients who complete the full 28-week program without reaching the stated weight-loss threshold
- Publishes both a phone number and an email address, and names its operating entity, Aspen Health Systems LLC
The caveats
- Compounded only, and compounded semaglutide and tirzepatide are not FDA-approved; no brand-name Wegovy, Zepbound, Ozempic or Mounjaro
- The 'Monthly Plan' is labeled 'Cancel anytime' but its own note says it is paid monthly with a three-month commitment and three months of medication shipped up front
- The site footer claims availability in 'all 50 U.S. states and Washington, D.C.' while its FAQ and its intake form both exclude Mississippi and Louisiana
- The clinician chooses semaglutide or tirzepatide for you — 'physician chosen for you' — so you cannot pick your own molecule
- Multi-month plans are billed up front and, per the site's own checkout text, are non-refundable for unused medication or remaining months
The verdict
Best for: People who want the full price ladder visible before they start and do not mind a clinician choosing semaglutide or tirzepatide on their behalf. Publishes every price tier before intake, but its 'monthly' plan bills three months upfront, the provider picks your molecule, and Mississippi and Louisiana are excluded.
Ranked #396 of 539 providers we have reviewed — for comparison, read what CoreAge Rx scores, and why, our #1 pick. In the ranking it sits between Sunlight at #395, 55/100 above and Embody at #397, 57/100 below, with the Nolu ruling the next one down.
Aspen is one of 539 rulings in this ranking, which makes the fair next question who sits above it — our shortlist of Aspen alternatives answers it in order, with every score shown.If you would rather start from the top of the field, our full board of 539 providers is the place to start if you are still shortlisting. We have also ruled on it directly: CoreAge Rx vs Aspen goes to CoreAge Rx, 94/100 to 57/100.
Compare with other providers
The closest rulings to Aspen by Verdict Score — the realistic shortlist if you are weighing this one up.
- #392Push Health— Push Health is a large US telehealth platform that routes brand-name GLP-1 prescriptions (Ozempic, Zepbound, Mounjaro) through a 55,000+ pharmacy network.58/100
- #393T2D.com— T2D.com offers a complete service for compounded semaglutide and tirzepatide that includes the prescriber, medication, and home delivery in one integrated solution.58/100
- #394Walgreens Weight Management— Walgreens virtual care program offering compounded GLP-1 medications through its retail pharmacy network.58/100
- #395Sunlight— A no-quiz FAQ answer states both molecule prices up front, but the homepage's own "injections and oral options" claim names an oral product the rest of the site never prices or names again.55/100
- #397Embody— Advertises low headline compounded GLP-1 prices, then quotes different figures across three funnels behind countdown timers and a promotional discount.57/100
- #398Nolu— An all-in per-order price with a rare oral route — but every figure on the site is billed per 4 weeks, not by the calendar month.57/100
Pricing, states and verification reflect Aspen's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Aspen's site. Not medical advice; see our disclosure.